P1239: BRUTON TYROSINE KINASE (BTK) PROTEIN DEGRADER BGB-16673 IS LESS APT TO CAUSE, AND ABLE TO OVERCOME VARIABLE BTK RESISTANCE MUTATIONS COMPARED TO OTHER BTK INHIBITORS (BTKI)
Xiaoyu Feng,
Yangyang Wang,
Tao Long,
Lanyue Bai,
Xiaojiao Yang,
Ailing Yang,
Xiangmei Chen,
Oscar Puig,
Yangbo Yue,
Zhirong Shen
Affiliations
Xiaoyu Feng
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Yangyang Wang
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Tao Long
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Lanyue Bai
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Xiaojiao Yang
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Ailing Yang
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Xiangmei Chen
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Oscar Puig
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Yangbo Yue
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
Zhirong Shen
1 Translational Discovery, Research and Medicine, BeiGene (Beijing) Co., Ltd, Beijing 100020, China
